|
|
April
18,
2009 -- 10:45pm EDT
Plavix and PPIs: Update
A
couple of months ago I
wrote about the confusion surrounding the
combination of Plavix and Proton Pump Inhibitors (PPIs) -- the FDA
had just issued a statement that there was concern that PPIs may interfere
with Plavix, the news media carried many stories warning of a potential
risk, but
the
ACC, AHA and SCAI urged patients not to change their medications without
consulting their cardiologists (Plavix is critical for stent patients
in order to reduce the risk of stent thrombosis).
So earlier today reader D.B., a pharmacist in California,
sent in this:
Great site. My wife had 2 stents inserted
in January and doing OK. My concern about PPI's and Plavix
brought me to your site. I believe your...article contains the latest
info. Are you aware of any new info? I'm planning to switch my wife from the
PPI, Protonix to a H2 blocker, Pepcid. Have
you read anything about the effectiveness of H2 blockers helping to control stomach
irritation
from Plavix & ASA? Thanks again for your site
and blog.
|
In fact, there are two recent updates.
One is a study in the current issue
of Thrombosis and Haemostasis, an official publication from
the European Society of
Cardiology. The article, "Impact
of proton pump inhibitors on the antiplatelet effects of clopidogrel",
shows a definite effect in the inhibition of clopidogrel's
antiplatelet function when using omeprazole (a.k.a. Prilosec) but,
interestingly enough, the other PPIs
tested showed no such effect. However, it was a study
that measured platelet reactivity and not clinical results, so
the
other PPIs are still not out of the woods. In fact an editorial
in the same issue recommends against the use of PPIs with Plavix
(clopidogrel) which goes against the recommendations of the American
societies.
The second update (or future update) may clear some of this up in a few
weeks. New results from the Medco
study are scheduled to be presented at the annual SCAI meeting in
Las Vegas May 6-9, so we'll be reporting on that when it breaks.
It will be interesting to see if guidelines and recommendations will
change as a result.
As for H2 blockers (like Pepcid) they were by and large
replaced when PPIs hit the market. There is question how effective
they are in this situation, and they also had some side-effects,
but were never shown to inhibit antiplatelet drugs like Plavix.
|
|
|